Definitive Contract 75N91019C00001

Award Date 12/19/18
Potential Completion Date 6/30/24
Potential Value $8.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,784,848.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract is for support services related to studies of infection, immunity, and cancer, and has a period of performance through July 5, 2024. Westat has extensive experience supporting federal agencies, including the NCI, across a range of public health, research,...
This is a federal contract award to Westat, Inc., a professional services firm, by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services. The $10,071,871.00 cost-plus-fixed-fee contract is for biomedical (applied/exploratory) services and has a completion date of September 29, 2005. The contract is not set aside. Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies,...
This is a $16,483,606.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm. The contract is for support services related to integrative epidemiological studies, with a period of performance through March 21, 2024. Westat has extensive experience working with federal agencies, including the NCI, on a variety of research, data collection, and program evaluation initiatives across public health, medical,...
This is a federal contract award to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract was awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (HHS). The contract is valued at $3,650,434.16 and is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract is for professional services and program management/support, with an ultimate completion date of July 31, 2021. Westat has...
This is a definitive contract awarded by the National Cancer Institute, part of the Department of Health and Human Services, to Westat, Inc., a for-profit professional services firm. The contract, valued at $18,272,174.00, is for developmental and technical services to support the Risk Factor Monitoring and Methods Branch. The contract does not have a set-aside designation. Westat has a history of providing a wide range of services to federal agencies, including survey research, data...
This is a $32,485,777.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm. The contract provides support services for the NCI's Infections and Immunoepidemiology Branch (IIB) and Integrative Tumor Epidemiology Branch (ITEB). The contract is part of the NCI's larger Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services indefinite delivery/indefinite quantity...
This is a federal contract awarded by the National Cancer Institute (NCI), a part of the U.S. Department of Health and Human Services, to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract, valued at $3,618,996.99, is for "Multi-Disciplinary Investigations of Nutrition and Cancer" and was awarded on August 30, 2007. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and has an ultimate completion date of March 16, 2015....
This is a $65,127,025.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm. The contract is for clinical genetics branch support services, including services such as site study setup, protocol writing, and electronic patient-reported outcomes collection for cancer clinical trials. Westat has extensive experience providing research, technical assistance, and program support services to federal agencies,...
This federal contract award, valued at $41,827,930.94, was issued by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract, which has no set-aside designation, is for the "DEVELOPMENT AND TECHNICAL SERVICES FOR THE NCI APPLIED RESEARCH PROGRAM" and has an ultimate completion date of August 31, 2014. Westat has extensive experience providing research, technical assistance, and program support services to...
This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract, titled "INTERDISCIPLINARY STUDIES OF OCCUPATIONAL AND ENVIRONMENTAL CANCER," has a ceiling value of $130,431,971.00 and a completion date of December 31, 2007. It is a cost-plus-fixed-fee contract, meaning the government reimburses the contractor for allowable costs incurred...

This is a $8,525,918.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Westat, Inc., a for-profit professional services firm. The contract is for support services for the Metabolic Epidemiology Branch of the NCI and has an ultimate completion date of June 30, 2024. The contract does not have a set-aside designation. Westat, Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with various agencies, including the Cancer Trials Support Unit IDIQ with the NCI to provide broad-based support services for cancer clinical trials.

Generated 7/12/24, 9:48 AM